Food and Drug Administration v. Alliance for Hippocratic Medicine

The Supreme Court unanimously held that plaintiffs lacked standing to challenge the FDA’s approval and regulatory changes to mifepristone, while reaffirming federal conscience protections for medical practitioners.

ReligiousLiberty.TV
February 28, 2026
0 min read
Cite This Case
Food and Drug Administration v. Alliance for Hippocratic Medicine (U.S. 2024).
✓ Copied! Standard law review / practitioner format. Verify against current Bluebook edition (21st ed.).

⚠ No official reporter citation found for this case. Citation quality will improve once a reporter citation (e.g. 573 U.S. 682) is added to the case record.

Food and Drug Administration v. Alliance for Hippocratic Medicine (U.S. Supreme Court, 2024). https://religiousliberty.tv/case-library/fda-v-alliance-for-hippocratic-medicine/
✓ Copied! For legal scholarship in social science journals. Includes URL back to this case page.

⚠ No official reporter citation found for this case. Citation quality will improve once a reporter citation (e.g. 573 U.S. 682) is added to the case record.

Food and Drug Administration v. Alliance for Hippocratic Medicine [U.S. Supreme Court, 2024] — The Supreme Court unanimously held that plaintiffs lacked standing to challenge the FDA's approval and regulatory changes to mifepristone, while reaffirming federal conscience protections for medical practitioners. Source: ReligiousLiberty.TV (https://religiousliberty.tv/case-library/fda-v-alliance-for-hippocratic-medicine/, accessed April 11, 2026).
✓ Copied! For general audiences, journalism, press releases, and non-legal writing.

⚠ No official reporter citation found for this case. Citation quality will improve once a reporter citation (e.g. 573 U.S. 682) is added to the case record.

Year: 2024 Court: U.S. Supreme Court
Holding: The Supreme Court unanimously held that plaintiffs lacked standing to challenge the FDA's approval and regulatory changes to mifepristone, while reaffirming federal conscience protections for medical practitioners.
Uses AI to generate a structured summary. Takes ~10 seconds.

Coverage on ReligiousLiberty.TV

📎 Document links found in our articles: 📄 static01.nyt.com PDF

Food and Drug Administration v. Alliance for Hippocratic Medicine is a Free Exercise case decided by the U.S. Supreme Court in 2024. The court held that the Supreme Court unanimously held that plaintiffs lacked standing to challenge the FDA's approval and regulatory changes to mifepristone, while reaffirming federal conscience protections for medical practitioners.